- Home
- PRKS vs RDY Comparison
PRKS vs RDY Comparison
Compare PRKS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- RDY
- Stock Information
- Founded
- PRKS 1959
- RDY 1984
- Country
- PRKS United States
- RDY India
- Employees
- PRKS N/A
- RDY N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- RDY Health Care
- Exchange
- PRKS Nasdaq
- RDY Nasdaq
- Market Cap
- PRKS 2.4B
- RDY 2.1B
- IPO Year
- PRKS 2013
- RDY N/A
- Fundamental
- Price
- PRKS $48.89
- RDY $14.94
- Analyst Decision
- PRKS Buy
- RDY Strong Buy
- Analyst Count
- PRKS 13
- RDY 2
- Target Price
- PRKS $57.85
- RDY $16.95
- AVG Volume (30 Days)
- PRKS 705.7K
- RDY 1.7M
- Earning Date
- PRKS 08-06-2025
- RDY 07-28-2025
- Dividend Yield
- PRKS N/A
- RDY 0.54%
- EPS Growth
- PRKS 3.53
- RDY 1.47
- EPS
- PRKS 3.85
- RDY 0.79
- Revenue
- PRKS $1,714,827,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- PRKS $2.47
- RDY $10.24
- Revenue Next Year
- PRKS $2.32
- RDY N/A
- P/E Ratio
- PRKS $12.68
- RDY $18.76
- Revenue Growth
- PRKS N/A
- RDY 16.61
- 52 Week Low
- PRKS $37.68
- RDY $12.26
- 52 Week High
- PRKS $60.83
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- PRKS 65.62
- RDY 46.58
- Support Level
- PRKS $44.61
- RDY $15.12
- Resistance Level
- PRKS $46.43
- RDY $15.71
- Average True Range (ATR)
- PRKS 1.29
- RDY 0.21
- MACD
- PRKS 0.65
- RDY -0.12
- Stochastic Oscillator
- PRKS 97.96
- RDY 3.54
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.